&w=3840&q=100)
Exciting to see Earth from vantage point of ISS: Shubhanshu Shukla
Shukla, who docked at the ISS on June 26 as part of the Axiom-4 mission, completed a week on the ISS and got a day off, which he spent connecting with family and friends back on Earth.
The Axiom-4 (Ax-4) crew, which includes Shukla and three other astronauts, completed 113 orbits around the Earth by the end of July 3, clocking over 4.66 million km, which is equivalent to nearly 12 times the distance between the Earth and the moon.
"It was a good moment. We got food from different countries and got to share it with all the crew," Shukla, who has the call sign Shux', said in a brief interaction with scientists at the URSC, Bengaluru over HAM radio connection.
On Thursday, Shukla also became the Indian astronaut with the longest stay in space, surpassing the record of his mentor Rakesh Sharma, who spent seven days, 21 hours and 40 minutes in space as part of the Soviet Interkosmos programme in 1984. As of Thursday, Shukla has spent nine days in space.
He said the most exciting part of the mission was looking back at Earth from the vantage point of the International Space Station.
Shukla said working with people from different countries too was an exciting experience.
Sharing his experience of the launch from the Kennedy Space Centre in Florida, Shukla said, "The rocket launch was very dynamic, it was very fast. As you go higher, you go faster and the accelerations were quite high." The Axiom-4 mission has veteran astronaut Peggy Whitson as commander, Shukla as pilot, and Polish astronaut Slawosz Uznanski-Wisniewski and Hungarian astronaut Tibor Kapu as mission specialists.
An Axiom Space statement said that in just seven days, the Ax-4 astronauts have already made significant contributions to scientific research.
"Peggy has been involved in cancer research using microgravity to study how tumour cells behave in space, work that is helping develop new therapeutic targets for metastatic cancers," the Axiom Space statement said.
"Shux has been conducting experiments that explore how microgravity affects the growth and genetic behaviour of algae and how tardigrades, hardy microscopic creatures, survive and reproduce in space," it said.
The findings of the experiments conducted by Shukla could reveal new insights into the molecular mechanisms of cellular resilience, which could translate into clinically relevant knowledge on Earth.
"A proud moment for India as our Indian Air Force officer becomes the first Indian military astronaut to board the InternationalSpaceStation (ISS) as part of AxiomMission4: First Indian in space after 40 years, Leading seven India-specific scientific experiments, representing India in over 60 global studies on Biology, Earth science & Material science," Science and Technology Minister Jitendra Singh said in a post on X.
"This milestone marks the resurgence of India's human spaceflight journey under the visionary leadership of Hon'ble PM Shri @narendramodi," Singh said.
During his amateur radio interaction, Shukla said global collaboration was the key to the success of a mission like the International Space Station.
"Agencies like NASA, ISRO, SpaceX, Axiom, ESA, JAXA, everyone is coming together to make this mission successful. I realise the power of global collaboration for making such missions happen. So, definitely global collaboration is the key," Shukla said.
Shukla is on a 14-day mission to the International Space Station as part of a joint ISRO-NASA project.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Hindu
26 minutes ago
- The Hindu
Scholarships: July 12, 2025
HOPE Engineering Scholarship An initiative from Schaeffler India Eligibility: Open to female students across India who are in the first year of an Engineering programme at any UGC or state-recognised college and have scored over 60% in Class 12 and have an annual family income of less than ₹500,000. Rewards: ₹50,000 a year for four years Application: Online Deadline: July 30 National Means-cum-Merit Scholarship Scheme Offered by the Department of School Education and Literacy, Government of India. Eligibility: Open to Indian nationals enrolled in Class 9 in a government, government-aided, or local-body school who have secured at least 60% in Class 8 with an annual family income of less than ₹3,50,000. Rewards: ₹12,000 per annum. Application: Online Deadline: August 31 National Fellowship and Scholarship for Higher Education of ST Students Offered by the Ministry of Tribal Affairs, Government of India Eligibility: Open to students from the Scheduled Tribe (ST) communities, who are 36 years or younger on July 1 and are enrolled in specified full-time, regular courses in ministry-approved institutions and have an annual family income of less than ₹600,000. Rewards: Up to ₹35,000 and other benefits. Application: Online Deadline: October 31 Courtesy:


The Hindu
26 minutes ago
- The Hindu
Enrolment in third phase clinical trials for India's first dengue vaccine nearly complete, says ICMR
Following an announcement by the Indian Council of Medical Research (ICMR) and Panacea Biotec Limited to initiate third phase trials, about 8,000 of the targeted 10,000 participants have enrolled in the third phase of clinical trials for a dengue vaccine in India, Manoj Murhekar, Director, National Institute of Epidemiology, ICMR, Chennai, told The Hindu. The trial will be rolled out at 20 centres across the country, Dr. Murhekar said. 'In India, all four serotypes of the dengue virus are known to circulate or co-circulate in many regions, so it's vital to ensure that we have an effective vaccine that achieves good efficacy for all four serotypes,'' he added. The trial is primarily funded by ICMR, with partial support from Panacea Biotec. Participants will be followed up for two years under projects spread across various centres, including Chennai, Pune, Hyderabad, and Delhi. There is currently no antiviral treatment or licensed vaccine for dengue in India. 'This landmark trial will evaluate the efficacy of India's indigenous tetravalent dengue vaccine, DengiAll, developed by Panacea Biotec. The first participant in this trial was vaccinated last year at Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak,'' a release issued by the Union Health Ministry said. The tetravalent dengue vaccine strain (TV003/TV005) originally developed by the National Institutes of Health, the U.S., has shown promising results in preclinical and clinical trials worldwide. Panacea Biotec, one of three Indian companies to receive the strain, is at the most advanced stage of developing a vaccine. The company has worked extensively on these strains to develop a full-fledged vaccine formulation and holds a process patent for this work. The first and second phases of the clinical trials of Indian vaccine formulations were completed in 2018-19, yielding promising results. Dengue is a major public health concern in India, which ranks among the top 30 countries with the highest incidence of the disease. The global incidence of dengue has been steadily increasing over the past two decades, with more than 129 countries reporting dengue viral disease by the end of 2023, according to the World Health Organization (WHO). In India, approximately 75-80% of infections are asymptomatic, yet these individuals can still transmit the infection through the bite of Aedes mosquitoes. Among the 20-25% of cases where symptoms are clinically apparent, children are at a significantly higher risk of hospitalisation and mortality. In adults, the disease can escalate into severe conditions, including the dengue hemorrhagic fever and dengue shock syndrome. The dengue virus has four serotypes, 1-4, with low cross-protection against each other, which means individuals can experience repeated infections.


United News of India
an hour ago
- United News of India
WHO recognises India's initiative in integrating AI with traditional medicine
New Delhi, July 12 (UNI) India's efforts in integrating Artificial Intelligence (AI) with traditional medicine systems have been recognised by the World Health Organization (WHO) in its newly released technical brief titled 'Mapping the Application of Artificial Intelligence in Traditional Medicine.' The document marks the first global roadmap on AI integration in traditional medicine and prominently features several Indian-led initiatives such as Ayush Grid and Ayurgenomics. It also acknowledged India as the first country to launch a Traditional Knowledge Digital Library (TKDL), reflecting its long-standing commitment to preserving and digitising traditional medicinal knowledge. The release of the technical brief follows a proposal made by India at the WHO Global Summit on Traditional Medicine, leading to the formulation of this document. Union Minister of State (Independent Charge) Ayush and Minister of State for Health & Family Welfare, Prataprao Jadhav, welcomed the recognition, noting that it reflects the deep commitment of Indian scientists and institutions. 'This underscores our alignment with Prime Minister Narendra Modi's vision to leverage technologies like AI to enhance the global relevance of Traditional Medicine,' he said. Jadhav cited several flagship platforms—SAHI portal, NAMASTE portal, and the Ayush Research Portal—as examples of how India is using digital technology to both preserve and globalise its traditional medicine systems. Vaidya Rajesh Kotecha, Secretary, Ministry of Ayush, stated that the WHO brief documents a slew of key AI-powered innovations from India, including Prakriti-based machine learning models for predictive diagnostics, AI applications for analysing pulse, tongue, and constitution types using neural networks among others. Further, the development of artificial chemical sensors to assess traditional parameters such as Rasa (taste), Guna (quality), and Virya (potency) was highlighted as a promising technological advancement in the standardisation of traditional formulations. The WHO brief also praised India's broader push toward digital health literacy among Ayush practitioners and efforts to build interoperable health systems that integrate traditional and allopathic medicine. The rise of online consultations and AI-powered diagnostic tools is considered an imperative part of a holistic push to modernise and expand access to traditional healthcare services. UNI AJ AAB GNK